Literature DB >> 6859391

A clinicopathologic review of 25 cases of chordoma (a pleomorphic and metastasizing neoplasm).

R Volpe, A Mazabraud.   

Abstract

A clinicopathologic study of 25 cases of chordoma revealed that this tumor occurs principally in (68%), with a predominance for the sixth decade of life (seven patients--28%), and shows a predilection for the sacrococcygeal region (52%). The symptomatology was intimately related to the location of the tumor. Histologically, chordoma showed an extremely wide range in its cellular composition and pattern, not only from tumor to tumor, but also often in different portions of the same tumor. In addition to the large physaliferous cells in a lobular arrangement, large cells with apparently degenerating nuclei (ghost cells) were commonly seen; cells arranged in concentric spherical formations were observed in two cases, whereas small, round cells predominated in another case. A sarcomatous pattern was prominent in two cases. Large pink cells were frequently seen and in one case were arranged in epithelial-like columns. Whether these neoplastic components can be related to different degrees of tumor differentiation is difficult to establish. Histologic features of five cases in which metastasis occurred were compared to previously described metastasizing cases. These appear to be few reliable features helpful in suggesting the metastatic potential of this neoplasm.

Entities:  

Mesh:

Year:  1983        PMID: 6859391     DOI: 10.1097/00000478-198303000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  30 in total

1.  Wandering chordoma--a mid-line crisis?

Authors:  David C Chhieng; Gene P Siegal
Journal:  Skeletal Radiol       Date:  2006-09-01       Impact factor: 2.199

2.  Pathobiology of selected tumors of the base of the skull.

Authors:  L Barnes
Journal:  Skull Base Surg       Date:  1991

3.  Osseous metastases of chordoma: imaging and clinical findings.

Authors:  Connie Chang; Ivan Chebib; Martin Torriani; Miriam Bredella
Journal:  Skeletal Radiol       Date:  2017-01-07       Impact factor: 2.199

4.  The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.

Authors:  Yunping Hu; Akiva Mintz; Sagar R Shah; Alfredo Quinones-Hinojosa; Wesley Hsu
Journal:  Carcinogenesis       Date:  2014-01-20       Impact factor: 4.944

5.  Recurrence of clival chordoma along the surgical pathway.

Authors:  N J Fischbein; M J Kaplan; R A Holliday; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

6.  DNA in chordomas of the clivus Blumenbachi.

Authors:  F W Spaar; U Spaar; E Markakis
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

Review 7.  The biology and pathology of selected skull base tumors.

Authors:  L Barnes; S B Kapadia
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Prognostic significance of immunohistochemical expression of VEGFR2 and iNOS in spinal chordoma.

Authors:  Reza Akhavan-Sigari; Michael Robert Gaab; Veit Rohde; Mehdi Abili; Helmut Ostertag
Journal:  Eur Spine J       Date:  2014-06-15       Impact factor: 3.134

9.  A lumbar chordoma treated with a wide resection.

Authors:  T Bas; P Bas; M Prieto; V Ramos; J L Bas; C Espinosa
Journal:  Eur Spine J       Date:  1994       Impact factor: 3.134

10.  Sacral chordoma: can local recurrence after sacrectomy be predicted?

Authors:  S A Hanna; W J S Aston; T W R Briggs; S R Cannon; A Saifuddin
Journal:  Clin Orthop Relat Res       Date:  2008-06-27       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.